Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
xCures
Var2 Pharmaceuticals
Degron Therapeutics Co.
Massive Bio, Inc.
LigaChem Biosciences, Inc.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Apollomics Inc.
Bayer
Shandong Cancer Hospital and Institute
Cedars-Sinai Medical Center
Sheffield Teaching Hospitals NHS Foundation Trust
Taproot Health
NGM Biopharmaceuticals, Inc
Prelude Therapeutics
ABM Therapeutics Corporation
Cedars-Sinai Medical Center
Hospices Civils de Lyon
Quadriga Biosciences, Inc.
Celgene
Hospices Civils de Lyon
AbbVie
SpeciCare
Celgene
Tocagen Inc.
Celldex Therapeutics
Stanford University
Icahn School of Medicine at Mount Sinai
Stanford University
AbbVie
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Pharmacyclics LLC.
Siemens Molecular Imaging